Offering a Suite of Clinical Grade Products for Any NGS Laboratory

Enable accurate, specialty testing for all patients.

Optimize treatment decisions and improve patient outcomes.

oncoReveal Solid Tumor Panel

The oncoReveal Solid Tumor v2 Panel is a robust 48-gene assay that simultaneously tests for key mutations present in solid tumors, including NSCLC, colorectal, melanoma, endometrial, pancreatic, GIST, bladder, thyroid, and gliomas. Additionally, genes with potential importance in immuno-oncology such as POLD1 and POLE are analyzed. The panel uses proprietary Stem-Loop Inhibition-Mediated amplification (SLIMampĀ®) technology, a tiled amplicon-based library prep chemistry for efficient single-tube target enrichment.
oncoReveal Solid Tumor v2 Panel (48 genes)

User Guide

Product Sheet

Pillar Biosciences' oncoReveal Multi-Cancer Panel performs congruently with the VAF % of Competitor X with an R squared of .9336
Pillar Biosciences Inc.
9 Strathmore Rd., Natick MA, 01740